AI assistant
Sending…
ANI PHARMACEUTICALS INC — Director's Dealing 2016
Feb 19, 2016
31676_dirs_2016-02-19_47d6b7ad-0c1d-4cb1-b4e6-a05c1597b841.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ANI PHARMACEUTICALS INC (ANIP)
CIK: 0001023024
Period of Report: 2016-02-18
Reporting Person: Schrepfer Robert W (VP Bus Dev & Con Mfg)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2016-02-18 | Common Stock | M | 6000 | $6.60 | Acquired | 25562 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2016-02-18 | Option to Purchase | $6.60 | M | 6000 | Disposed | 2023-07-31 | Common Stock (6000) | Direct |
More from ANI PHARMACEUTICALS INC
Regulatory Filings
2026
May 21
Regulatory Filings
2026
May 13
Interim / Quarterly Report
2026
May 8
Regulatory Filings
2026
May 8
Annual Report
2026
Apr 9
Proxy Solicitation & Information Statement
2026
Apr 9
Regulatory Filings
2026
Apr 7
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Mar 4
Regulatory Filings
2026
Mar 3